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Abstract 1 
Background: Internationally, foot trimming is used by most farmers and parenteral antibacterials 2 
by some, to treat sheep with footrot. Non steroidal anti-inflammatory drugs (NSAID) are 3 
sometimes used. No clinical trials have compared these treatments. 4 
Objectives: To investigate the above treatments on time to recovery from lameness and foot 5 
lesions in sheep with footrot. 6 
Animals: 53 sheep with footrot on a commercial farm in England. 7 
Methods: In a randomised factorial design, the sheep were allocated to 6 treatment groups. The 8 
treatments were oxytetracycline spray to all sheep (positive control) and one or more of: 9 
parenteral administration of long acting oxytetracycline, flunixine meglumine and foot trimming 10 
on day 1 or day 6 of diagnosis. Follow-up was for 15 days. Time to recovery from lameness and 11 
lesions was investigated with discrete- time survival models.  12 
Results: There was significant association (p<0.05) between recovery from lameness and lesions. 13 
Sheep receiving antibacterials parenterally recovered faster from lameness (odds ratio (OR): 4.92 14 
(1.20-20.10)) and lesions (OR: 5.11 (1.16-22.4)) than positive controls whereas sheep foot 15 
trimmed on day 1 (lameness- OR: 0.05 (0.005-0.51); lesions- OR: 0.06 (0.008-0.45)) or day 6 of 16 
diagnosis (lameness-OR: 0.07 (0.01-0.72); lesions- OR: 0.07 (0.01-0.56)) recovered slowly than 17 
positive controls. NSAID had no significant effect on recovery.  18 
Conclusions and Clinical Importance:  If foot trimming on day 1 or 6 of diagnosis was stopped 19 
and parenteral antibacterials were used, then over 1 million sheep/annum lame with footrot in the 20 
UK, would recover more rapidly with benefits to productivity. Globally, this figure would be 21 
much higher. 22 
23 
 3 
Introduction 1 
Footrot causes lameness in sheep throughout the world and is an important health, welfare and 2 
economic concern. Over 90% of flocks in the UK have lame sheep, with a within flock 3 
prevalence of ~ 10% 
1, 2
. Warm, wet environmental conditions favour the spread of footrot
3
 and 4 
the severity of clinical presentation. Virulent footrot presents clinically
3
 with separation of hoof 5 
horn from the sensitive dermis with a characteristic smell 
4
. It causes approximately 30%, and 6 
interdigital dermatitis (often benign footrot
5
) 50 – 60%, of lameness in sheep in the UK2. Benign 7 
and virulent footrot are caused by Dichelobacter nodosus. Over 95% of isolates of D. nodosus 8 
from the UK are virulent by laboratory tests
5
, irrespective of serogroup and clinical presentation. 9 
Laboratory diagnosis is of limited value to diagnose individuals because culture and PCR give 10 
false positive and negative results. It is used to determine flock infection and control in countries 11 
where there are control policies whereas elsewhere clinical presentation is used.  12 
Treatments for footrot include one or more of: trimming hoof horn, parenteral antibacterials and 13 
topical bactericide 
6, 7
. The most popular treatment for footrot is trimming and applying a topical 14 
bactericide, with more than 90% farmers in the UK using this treatment in 2000
8
 and 2004
9
. 15 
Trimming removes excess horn and exposes footrot lesions to air 
7, 10
; ‘letting air in’ was 16 
recommended to combat D. nodosus because of its anaerobic nature
6, 11
. Some practitioners 17 
propose severe trimming of the hoof horn at diagnosis
12
, however, many have moved away from 18 
this and recommend that hoof horn is trimmed carefully 5 days after treatment, when the lesions 19 
have start to heal
7, 13
, there is no evidence for or against this latter recommendation. All foot 20 
trimming runs the risk of damaging the sensitive dermis of the foot, causing pain and 21 
granulomatous proliferations
3, 7
.  22 
In the UK, two epidemiological studies led to the hypothesis that parenteral and topical 23 
antibacterials were the most effective treatment for footrot 
8, 14
. From clinical trials in Australia 24 
 4 
and the UK ~ 90% sheep were cured after treatment with penicillin and streptomycin
15
, 1 
lincomycin and lincospectin
16
, erythromycin
17
 and long acting oxytetracycline
18,19
. However, in 2 
these trials no observations were made on lameness, only lesions, and all sheep were examined 3 
for the first time 4-5 weeks after treatment so there is no estimate of time to recovery. Foot 4 
trimming was combined with all treatments so the impact of trimming on recovery was not 5 
elucidated. Some farmers treat lame sheep with NSAID which have anti-inflammatory, anti-6 
pyretic and analgesic properties that provide symptomatic relief from inflammatory conditions
20, 
7 
21
; their efficacy has not been evaluated.  8 
There is no clinical trial that compares all treatments under similar conditions. The aim of the 9 
current study was to investigate the effects of long acting parenteral oxytetracycline, foot 10 
trimming on the same day or day 6 of diagnosis and flunixin meglumine (NSAID) on the time to 11 
recovery from lameness and foot lesions in sheep lame with footrot. 12 
13 
 5 
Materials and Methods 1 
Study design 2 
A randomised factorial-design clinical trial was conducted on a farm in England, with a history of 3 
sheep with footrot between October and December 2007. The flock comprised 250, 9-month-old 4 
ewes that were out-wintered and not pregnant. The farmer put three replicates of 18, 32 and 10 5 
lame sheep into a field on 18/10/2007, 14/11/2007 and 5/12/2007 respectively. The lame sheep 6 
were identified with an ear tag and their locomotion
22 
was scored by researchers. The feet were 7 
inspected and sheep with footrot (separation of the hoof horn and a characteristic smell) were 8 
recruited into the trial. The severity of lesions on each foot was recorded
23
. These sheep were 9 
lame for up to 2 weeks before they were recruited in the trial. Sheep lame for any other reason 10 
were treated using recommended treatments 
7
 and returned to the main flock.  11 
 12 
Allocation to treatment groups 13 
The 53 sheep (replicate 1=14, replicate 2=29, and replicate 3=10) were matched by maximum 14 
lesion severity and randomly allocated to one of six treatments (Table 1) by selecting a coloured 15 
ball from a bag. The treatments were antibacterial aerosol spray to all sheep and then parenteral 16 
administration of antibacterials on day 1 of diagnosis (n=34), NSAID on day 1 of diagnosis 17 
(n=8), foot trimming on day 1 (n=15) and foot trimming on day 6 (n=21) of diagnosis in an 18 
incomplete factorial design
24, 25
. The experimental protocol was approved by the Home Office as 19 
a comparison of currently used methods to treat footrot and therefore ethically acceptable. The 20 
researchers and farmer also discussed the treatments and the farmer approved them for his sheep. 21 
 22 
The parenteral antibacterial was a long acting preparation of oxytetracycline
a
 (200mg/ml) at a 23 
dose of 1ml/10kg bodyweight by deep intramuscular injection with a maximum dose of 5ml per 24 
 6 
site. The aerosol spray was terramycin
b
 (oxytetracycline hydrochloride PhEur (3.93% w/w). The 1 
NSAID used was flunixin meglumine BP
c
 at a dose of 2ml/45kg by intramuscular injection. 2 
Sheep were diagnosed and treated by two researchers (SLSD and JLW) trained by JK. All foot 3 
trimming was done by the farmer who was blinded to the treatment allocation. This farmer had 4 
been sheep farming for 15 years and did not trim feet severely when he trimmed them 5 
(observations of SLSD and JLW). All selected sheep on day 1 and only sheep still lame on day 6 6 
of diagnosis allocated to be trimmed were foot trimmed. 7 
  8 
Follow up 9 
Sheep locomotion was scored
22
 and their feet inspected and lesions scored on three occasions 10 
each week for up to 15 days. All sheep not returning to locomotion score zero by 15 days were 11 
inspected and those with footrot or interdigital dermatitis were treated with parenteral 12 
antibacterials and antibacterial spray.  13 
 14 
Statistical analysis 15 
Outcome and model set up 16 
Data were stored in Microsoft Access. The outcomes of interest were time to recovery from 17 
lameness and time to recovery from footrot lesions. A sheep was defined as recovered from 18 
lameness when it had a locomotion score of zero for two consecutive observations. Recovery 19 
from footrot lesions occurred when the lesion had healed and there was no foul smell or exudates.  20 
Discrete time survival analysis
26 
modelling hazard probability for recovery was used to analyse 21 
the data
d
. For both lameness and lesions the time to recovery was divided into three discrete-time 22 
periods 1-5 days (T1), 6-10 days (T2) and 11-15 days (T3) and sheep either recovered or not in 23 
each time period. The hazard probability is the conditional probability that an event occurs in a 24 
 7 
particular time period, given that it has not occurred in the previous time period (s) and is 1 
described by an odds ratio.  2 
Data were converted into sheep-period format with a separate record for each discrete time that a 3 
sheep had a probability of recovering. For each of these time periods a binary variable was used 4 
to indicate whether recovery occurred or not. Sheep were excluded from all subsequent time 5 
periods once they had recovered and those not recovered by 15 days were right censored.   6 
 7 
The model took the form
26
: 8 
logit h (Tit) = [α1T1it+ α 2T2it+ α 3 T3it] + [β1X1it+ β2X2it…….+ βPXPit] 9 
 10 
Predictor variables 11 
The predictor variables were discrete time periods (T1, T2, T3) , did or did not receive parenteral 12 
administration of antibacterial or NSAID on day 1 of diagnosis, the time dependent variable no 13 
foot trimming, foot trim on day 1 or day 6 of diagnosis, with a positive control of receiving 14 
topical antibacterials (Table 2), locomotion score at the start of the trial (locomotion score ≤ 2 or 15 
3), number of feet affected with footrot (1 or 2), replicate (1, 2 or 3) and severity of footrot 16 
lesions (score 1 or 2). Interactions between the variables were investigated. Observations that 17 
clustered within sheep were included as a random effect. 18 
The adjusted odds ratio (OR) (the hazard probability ratio) and associated 95% confidence 19 
intervals were estimated. The model fit was evaluated by examining the deviance residuals at 20 
sheep-period level and the sum of squared deviance residuals for each sheep’s contribution to the 21 
deviance statistic 
26
. The association between recovery from lameness and healing of footrot 22 
lesions was assessed using a χ 2 test for each time period. The predicted probability for recovery 23 
from lameness and footrot lesions in the discrete time period was plotted. 24 
 8 
Results 1 
On day 1 of diagnosis, 1 sheep had a locomotion score 1, 19 a score 2 and 33 had a locomotion 2 
score 3. Sixty eight percent of sheep (36/53) had one foot affected with footrot and 32% (17) had 3 
two feet affected and 60% (32) had a footrot severity score 1 and 40% (21) had a severity score 2. 4 
The environmental conditions were fairly similar for each replicate; temperatures ranged from 7 5 
to 11° C with a rainfall of 45 to 50 mm during the trial
27
. Sheep were moved straight to pasture 6 
after treatment, the weather was mostly dry for the 24 hours after treatment but moisture levels 7 
due to dew are unknown. The proportion of sheep allocated to each treatment in each replicate 8 
was similar (Table 2).  9 
 10 
Approximately 51% (27/53) of sheep recovered from lameness during T1, 55% (14/26) during T2 11 
and 58% (7/12) during T3. The time to recovery from lameness and lesions was significantly 12 
associated (p<0.05). Lameness and foot lesions resolved in the same time period except for 4 and 13 
1 sheep that were still lame at the end of T1 and T2 respectively but had no lesions; these sheep 14 
recovered from lameness in the following time period. Recovery rates were not significantly 15 
different between the three discrete time periods (Table 3). Five sheep were still lame and had 16 
lesions at the end of T3; all had been foot trimmed, one had been treated with parenteral 17 
antibacterials. 18 
 19 
Sixty-five percent (22/34) of sheep that received antibacterials administered parenterally 20 
recovered from lameness and 76% (26/34) from lesions in T1. Nine of the remaining 12 sheep and 21 
5 / 8 sheep with lesions, recovered from lameness and lesions respectively in T2. Only 26% 22 
(5/19) of sheep that did not receive parenteral administration of antibacterials recovered from 23 
both lameness and lesions in T1 and a further 36% (5/14) and 43% (6/14) recovered from 24 
 9 
lameness and lesions respectively in T2. Sheep that received parenterally administered 1 
antibacterials were significantly more likely to have a faster recovery from both lameness (OR: 2 
4.92 (1.20-20.10)) and lesions (OR: 5.11 (1.16-22.40)) than positive controls. There was no 3 
significant effect of NSAID on the time to recovery from lameness (Table 3).  4 
 5 
Four out of 15 trimmed sheep recovered from lameness and 5/15 from lesions in T1. There were 6 
12 sheep that were still lame by day 6 of diagnosis that were foot trimmed, 3/12 recovered from 7 
both lameness and lesions in T2. Sheep that were trimmed on day 1 (lameness - OR: 0.05 (0.005-8 
0.51); footrot lesions- OR: 0.06 (0.008-0.45)) or day 6 (lameness- OR: 0.07 (0.01-0.72); footrot 9 
lesions- OR: 0.07 (0.01-0.56)) of diagnosis were significantly less likely to recover in the time 10 
period than sheep that were not trimmed (Table 3). 11 
 12 
The overall estimated hazard probability for recovery from both lameness and lesions within 5 13 
days of treatment was highest in sheep that were treated with parenterally administered 14 
aantibacterials without foot trimming (Figure 1) followed by positive controls and sheep that 15 
were foot trimmed and given parenteral administration of antibacterials and was lowest in sheep 16 
that were foot trimmed and not given parenteral administration of antibacterials.  17 
 18 
Sheep with a locomotion score 3 took longer to recover from lameness (OR: 0.05 (0.01-0.24)) 19 
and lesions (OR: 0.04 (0.007-0.21)) than sheep with locomotion score ≤2. There was no 20 
significant effect of number of feet affected or severity of footrot lesions or replicate on the time 21 
to recovery from lameness or lesions (Table 3). 22 
 23 
 10 
There were no statistically significant interactions between treatments. The models provided a 1 
reasonable fit to the data (Hosmer–Lemeshow statistic, lameness (p=0.93), lesions (p=0.52)). 2 
There were no extreme observations with large residuals in the index plots of deviance residuals.  3 
Discussion 4 
In this trial sheep treated with parenteral administration of long acting oxytetracycline (together 5 
with an oxytetracycline spray) were significantly more likely to recover from footrot lesions and 6 
lameness within 5 days of treatment compared with sheep that were foot trimmed with or without 7 
parenteral administration of antibacterials or positive controls (Table 3). The explanation for this 8 
rapid response to treatment might be that D. nodosus is a bacterium susceptible to all antibacterial 9 
classes and that the antibacterials administered parenterally penetrated deep into the dermis 10 
where D. nodosus can be present 
15
. The results fit with the cure percents for parenteral 11 
administration of antibacterials from other studies but we recorded time to recovery from both 12 
lameness and lesions which was rapid. The results from the current study suggest that parenteral 13 
administration of antibacterials is very effective (with 75% sheep recovering within 5 days) in 14 
minimising the time that sheep are lame and thus treating all lame sheep with footrot with them 15 
could not only improve the health and welfare of the sheep but could also minimise the effects of 16 
chronic lameness on loss of body condition and reduced productivity, such as lambs born and 17 
lamb growth rate 
28
 . 18 
 19 
Sheep in the current study were moved straight to pasture after treatment with parenteral 20 
antibacterials. Previous evidence suggests that a dry environment for 24 hrs after parenteral 21 
treatment is important 
15 
for improved efficacy of short acting parenteral antibacterials. Thus it is 22 
possible that for long acting preparations with therapeutic levels present in serum for at least 72 23 
 11 
hours 
29
 , provision of a dry environment for up to 24 hrs is not be essential, especially 1 
considering that the majority of sheep recovered within 5 days of treatment.  2 
Foot trimming sheep lame with footrot without administration of antibacterials parenterally was 3 
associated with the longest time to recovery from lameness and lesions both when sheep were 4 
trimmed on day 1 or day 6 of diagnosis, suggesting that foot trimming lame sheep had a 5 
detrimental effect on recovery whether the lesions were active or healing. For discrete time model 6 
the odds of recovery from lameness or lesions within each 5 day period were similar for sheep 7 
trimmed on day 1 or day 6 of diagnosis, suggesting that time of trimming did alter the time to 8 
recovery differentially. In addition, lame sheep trimmed on day 6 of diagnosis were compared to 9 
sheep still lame at day 6, avoiding selection bias. Trimmed sheep were lame and had lesions for 10 
twice as long as the non-trimmed sheep, and presumably were infectious for twice as long, if we 11 
assume that infectiousness is correlated with the presence of lesions. The delay in recovery 12 
among trimmed sheep might be because trimming the hoof horn aggravated the foot and delayed 13 
healing because of physical damage to the foot. The farmer did not trim feet severely and it is not 14 
unreasonable to assume that his trimming practice is similar to other farmers who trim feet 15 
without causing them to bleed. It is quite possible that had there been ‘severe’ trimming and 16 
damage to the dermis that the time to recovery might have been longer.  17 
The combination of antibacterials administered parenterally, foot trimming and foot spraying had 18 
a similar time to recovery from lameness and lesions as antibacterial spray alone, suggesting that 19 
parenteral administration of an antibacterial agent negated the negative effect of foot trimming 20 
but did not lead to as rapid a recovery from lameness as these antibacterials without foot 21 
trimming. Quite remarkably, sheep that were not foot trimmed and did not receive parenteral 22 
antibacterials, but only an oxytetracycline spray (as were all sheep in this study) recovered more 23 
quickly than those foot trimmed and given topical spray (Figure 1), suggesting that foot trimming 24 
 12 
cannot be recommended as a ‘second best’ treatment where farmers do not wish to use 1 
antibacterials administered parenterally but rather it is detrimental to recovery from lameness and 2 
lesions.  3 
In the current study, sheep with a higher locomotion score at the start of the study took longer to 4 
recover, suggesting an association between the severity of lameness and time to recovery from 5 
footrot lesions and lameness. There was no significant association between the severity of the 6 
initial lesion (even in univariate analysis) and the time to recovery from lesions or lameness, also 7 
reported elsewhere 
17, 19.
 . It is possible that the classification of under-run area (Table 3) was 8 
insufficient to detect a difference or that the sheep rate of healing is such that severe lesions heal 9 
as rapidly as mild lesions. A positive association between presence of lesions and lameness was 10 
also observed in a longitudinal study
9
. We hypothesise that lesions cause lameness. 11 
Consequently, sheep with old and chronic lesions and / or extensive damage to the wall horn 12 
might take longer to recover from lameness if the lesions take longer to heal. However in an 13 
intervention study
23
 sheep lame for several months after treatment with parenteral antibacterials 14 
recovered in median time of 4 days. This might suggest that given appropriate treatment the 15 
propensity for the sheep foot to heal is great. 16 
The lack of association between the number of feet with footrot and time to recovery from footrot 17 
contrasts with a previous study 
19
 where sheep with 1 or 2 feet affected had higher cure rates than 18 
sheep with 3 or 4 feet affected. However, because sheep had a maximum of two feet affected in 19 
the current study it was not possible to investigate the relationship between more than this 20 
number of affected feet and recovery.  21 
NSAID did not change the time to recovery from lameness significantly, possibly because 8 22 
sheep received NSAIDS or because they were given for only one day. A previous study 
30
 23 
suggested that after 3-days administration of flunixine meglumine noxious mechanical 24 
 13 
stimulation to sheep with footrot responses were comparable to healthy sheep. NSAID do 1 
produce analgesia for up to 24 hrs and so one injection might help ewes to continue to feed and 2 
allow their lambs to feed, it certainly should not be discounted because of the results from the 3 
current study.   4 
No non-lame sheep were foot trimmed in this study and it is only possible to hypothesise on the 5 
impact of routine foot trimming from other studies 
8, 14, 31 
where trimming was positively 6 
correlated to lameness. Foot trimming might cause damage to the foot and spread or increase 7 
susceptibility to D. nodosus or it might be indirectly causal if farmers trim rather than treat lame 8 
sheep 
32
. Untreated sheep with footrot can remain lame for many months. 9 
This study is an example of reduction and refinement in use of animals in experiments. A 10 
factorial design comparing the effects of several treatments individually and in combination used 11 
a relatively small number of sheep (53) with sufficient power, possibly with the exception of 12 
NSAID. In the absence of a gold standard laboratory test, sheep were diagnosed using 13 
characteristic clinical presentation. The researchers were not blinded to treatment allocation 14 
which could lead to bias, however, during follow up, sheep number was used to identify 15 
individual animals and it seems unlikely that researchers remembered the identity of a sheep and 16 
its treatment. The use of one flock and one environment gave consistency to compare the 17 
effectiveness of the treatments and avoided confounding factors such as differences in breed, age, 18 
micro and macro environment and other factors 
19
 that vary between farms. Further studies are 19 
required to externally validate these findings and to investigate the effect of trimming feet of non-20 
lame sheep.  21 
 22 
 23 
 24 
 14 
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Table 1: Number of sheep and treatment given in the factorial design  1 
 Parenteral 
antibacterial at 
day 1 of 
diagnosis 
Foot trimming at 
day 1 of diagnosis 
Foot trimming at 
day 6 of 
diagnosis 
Non steroidal 
anti- 
inflammatory 
drug at day 1 
of diagnosis 
Treatment group 1 (n=9) 9 0 0 0 
Treatment group 2 (n=8) 8 0 0 8 
Treatment group 3  (n=7) 7 7 0 0 
Treatment group 4  (n=10) 10 0 10* 0 
Treatment group 5  (n=8) 0 8 0 0 
Treatment group 6  (n=11) 0 0 11* 0 
Total (n=53) 34 15 21 8 
* 5 lame sheep from Treatment group 4 and 7 lame sheep from Treatment group 6 were trimmed 2 
because 5 and 4 sheep from these groups recovered before day 6 respectively. 3 
4 
 20 
Table 2: Distribution of sheep in treatment groups by replicate and footrot severity 1 
 Replicate 1 Replicate 2 Replicate 3 Footrot severity  
score 1 
Footrot severity 
 score 2 
Treatment 
Group 
Number 
of sheep 
Percent 
(%) 
Number 
of sheep 
Percent 
(%) 
Number 
of sheep 
Percent 
(%) 
Number 
of sheep 
Percent 
(%) 
Number 
of sheep 
Percent 
(%) 
1 2 14.3 5 17.2 2 20.0 5 15.6 4 19.0 
2 2 14.3 5 17.2 1 10.0 5 15.6 3 14.3 
3 2 14.3 4 13.8 1 10.0 4 12.5 3 14.3 
4 3 21.4 5 17.2 2 20.0 6 18.8 4 19.0 
5 2 14.3 4 13.8 2 20.0 5 15.6 3 14.3 
6 3 21.4 6 20.7 2 20.0 7 21.9 4 19.0 
Total 14 100.0 29 100.0 10 100.0 32 100.0 21 100.0 
2 
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Table 3: Multivariable discrete time survival analysis of time to recovery from lameness and 1 
footrot lesions of 53 sheep with footrot after treatment with combinations of parenteral long 2 
acting oxytetracycline at day 1 of diagnosis, NSAID at day 1 of diagnosis and foot trimming at 3 
day 1 or day 6 of diagnosis 4 
Predictor Variable 
Lameness Footrot lesions 
No. of 
sheep obs. 
OR 95% C.I. p-value No. of 
sheep obs. 
OR 95% C.I. p-value 
T3  (time period 3) 12 Ref.   11 Ref.   
T1  (time period 1) 53 0.28 0.04-1.98 0.20 53 0.15 0.02-1.31 0.09 
T2  (time period 2) 26 1.71 0.26-11.04 0.57 22 0.71 0.08-6.11 0.75 
Parenteral LAO at day 1 
of diagnosis- No 
42 Ref.   41 Ref.   
Yes 49 4.92 1.20-20.1 0.02 45 5.11 1.16-22.4 0.03 
NSAID at day 1 of 
diagnosis-No 
81 Ref.   78 ^   
Yes 10 1.64 0.28-9.57 0.57 8    
Foot Trimming at day 1 
of diagnosis - No 
76 Ref.   71 Ref.   
Yes 15 0.05 0.005-0.51 0.003 15 0.06 0.008-0.45 0.006 
Foot Trimming at day 6 
of diagnosis- No 
79 Ref.   74 Ref.   
Yes 12 0.07 0.01-0.72 0.009 12 0.07 0.01-0.56 0.01 
Locomotion score at the 
start of the trial= ≤ 2# 
26 Ref.   25 Ref.   
Locomotion score at the 
start of the trial= 3## 
65 0.05 0.01-0.24 <0.001 61 0.04 0.007-0.21 <0.001 
No. of feet affected =1 59 Ref.   56 Ref.   
No. of feet affected =2 32 0.84 0.24-2.93 0.79 30 0.84 0.26-2.65 0.77 
Replicate 1 20 Ref.   20 Ref.   
Replicate 2 47 0.71 0.16-3.09 0.65 43 0.92 0.26-3.21 0.90 
Replicate 3 24 0.43 0.08-2.05 0.28 23 0.67 0.18-2.51 0.56 
Footrot severity score 1*  53 Ref.   50 Ref.   
Footrot severity score 
2**  
38 1.28 0.38-4.27 0.68 36 0.83 0..21-3.24 0.80 
LAO, long acting oxytetracycline; OR, odds ratio; obs., observations;  Ref., reference; # ,Visible nodding of head in 5 
time with short stride and/or uneven posture, shortened stride on one leg; ## ,Uneven posture, shortened stride on 6 
one leg, excessive flicking of head more than nodding in time with short stride; *,<50% of heel/sole/wall 7 
separation;**,≥50% and <100% heel/sole/wall separation; ^ coefficient could not be estimated because all sheep 8 
recovered in T1 9 
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Figure 1: The fitted hazard probability of recovery from lameness and footrot lesions within 5 1 
days when treated with or without a parenteral antibacterial injection with no foot trimming or 2 
foot trimming at discrete times T1 and T2   3 
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Black bar: parenteral antibacterial and no foot trimming; White bar with grid:  no parenteral 6 
antibacterial injection and no foot trimming; White bar with cross hatches: parenteral 7 
antibacterial injection and foot trimming; Grey bar: no parenteral antibacterial injection and foot 8 
trimming. 9 
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